Global Gene Panel Market 2020-2024 | Evolving Opportunities With ArcherDx Inc. and Agilent Technologies Inc. | Technavio
LONDON--(BUSINESS WIRE)--Dec 18, 2019--
Technavio has been monitoring the global gene panel market and the market is poised to grow by USD 1.72 billion during 2020-2024 at a CAGR of about 18% during the forecast period. Request Free Sample Pages
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191218005502/en/
Technavio has announced its latest market research report titled global gene panel market 2020-2024. (Graphic: Business Wire)
Read the 149-page research report with TOC on “Gene Panel Market Analysis Report by Geography (Asia, Europe, North America, and ROW), by Product (Small panel testing and Large panel testing), and Segment Forecasts, 2020-2024.”
The growing use of gene panels in cancer-targeted therapies and rising use of direct-to-consumer tests is anticipated to boost the growth of the market.
Pharmaceutical companies are investing heavily in research activities to develop targeted therapies for the treatment of cancer. This is driving the demand for gene panels as they are used in the development of targeted therapies for cancer. Gene panel testing provides a wide range of benefits such as providing the genetic basis of an individual’s response to therapy. NGS-based gene panel tests are becoming popular as the first choice for cancer care as they are cost-effective, provide genomic data in a short time, and examine only clinically important genes. This is driving the use of gene panels to evaluate effective treatments for cancer, which is expected to drive market growth during the forecast period.
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
Major Five Gene Panel Market Companies:
Agilent Technologies Inc.
Agilent Technologies Inc. is headquartered in the US and operates the business under various segments such as Life sciences and applied markets, Diagnostics and genomics, and Agilent CrossLab. The company offers ClearSeq Comprehensive Cancer, ClearSeq Inherited Disease Panel, ClearSeq RNA Kinome, and OneSeq CNV Backbone + SureSelect Custom Panels.
ArcherDx Inc. is headquartered in the US and offers products through the following business units: Products and Services. The company offers FusionPlex, VariantPlex, LiquidPlex, Immunoverse, and Custom Panels.
BGI Genomics Co. Ltd.
BGI Genomics Co. Ltd. is headquartered in China and operates under various business segments, namely Molecular Genetics, Sequencing Services, Mass Spectrometry, and Pharma Solutions. The company offers SENTIS – Oncology, Oseq Hereditary Cancer Panel, and Oseq Solid Tumor Panels.
Eurofins Scientific SE
Eurofins Scientific SE is headquartered in Luxembourg and offers products through the following business segments: Western Europe, North America, and ROW. The company offers a targeted gene panel, INVIEW Panel Products.
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. is headquartered in Switzerland and offers products through the following business segments: Pharmaceuticals and Diagnostics. The company offers AVENIO NGS Oncology Assays and RealTime ready Human Reference Gene Panel.
Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio’s SUBSCRIPTION platform
Gene Panel Product Outlook (Revenue, USD Million, 2020-2024)
Gene Panel Regional Outlook (Revenue, USD Million, 2020-2024)
Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more.Request a free sample report
Related Reports on Health Careinclude:
Gene Therapy for Inherited Genetic Disorders Market – Global Gene Therapy for Inherited Genetic Disorders Market by application (eye disorders, hematological disorders, central nervous system disorders, muscular disorders, and others) and geography (Asia, Europe, North America, and ROW).
Gene Therapy for CNS Disorders Market – Global Gene Therapy for CNS Disorders Market by indication (SMA and others) and geography (Asia, Europe, North America, and ROW).
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
View source version on businesswire.com:https://www.businesswire.com/news/home/20191218005502/en/
CONTACT: Technavio Research
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH
SOURCE: Technavio Research
Copyright Business Wire 2019.
PUB: 12/18/2019 08:00 PM/DISC: 12/18/2019 08:00 PM